These innovative treatments, Tirzepatide , represent a groundbreaking advancement in addressing type 2 diabetes and possibly other conditions . They all are grouped as GLP-1 hormone activators , meaning these substances to mimic the endogenous GLP-1 hormone , enhancing insulin secretion and suppressing food intake. Despite Semaglutide each function